Judith Prochaska, PhD, MPH

Professor of Medicine with the Stanford Prevention Research Center

Member of the Stanford Cancer Institute

Bio:

Judith (Jodi) Prochaska, PhD, MPH is a Professor with the Stanford Prevention Research Center in the Department of Medicine at Stanford University and a member of the Stanford Cancer Institute. Her research program is leveraging technology (e.g., web, text, social media) to bring tobacco cessation treatment into novel settings and to populations with high smoking prevalence. Dr. Prochaska is a fellow and past president of the Society for Research on Nicotine and Tobacco (SRNT). She has published >200 peer-reviewed articles and serves on the Editorial Boards of JAMA Internal Medicine and Health Psychology.

Estela Lajthia, Pharm.D.

Clinical Assistant Professor

Bio:

Dr. Estela Lajthia is a Clinical Assistant Professor of Pharmacy Practice at Howard University College of Pharmacy (HUCOP) since 2017. She receive her Doctorate of Pharmacy Degree from Shenandoah University – Bernard J. Dunn School of Pharmacy and completed a 2-year combined PGY-1/PGY-2 in Ambulatory Care with a focus in Academia at Virginia Commonwealth (VCU) School of Pharmacy after graduation. During her residency training at VCU Dr. Lajthia practiced at a local safety net clinic, Crossover HealthCare Ministries, which is a patient-centered medical home (PCMH). She led pharmacist-driven clinics and precepted pharmacy students while providing a multitude of clinical services to the diverse patient populatioin. Some of these services included diabetes management, anticoagulation therapy management, smoking cessation, medication reconciliation services, hypertension and hyperlipidemia management. 

Since joining Howard University in 2017, she has served as the clinical pharmacist at the Diabetes Treatment Center (DTC), which is an outpatient endocrine clinic at Howard University Hospital. Dr. Lajthia is the only pharmacist among the interprofessional DTC team that consists of endocrinologists, nutritionist, medical fellows, diabetes educators and nurses. She provides comprehensive medication therapy management and education for patients with diabetes, hypertension, heart disease, hyperlipidemia, kidney disease, nicotine dependence, thyroid disorders etc. Furthermore, Dr. Lajthia has extensive teaching experience as a lecturer and coordinator. For the last three years she has coordinated, prepared and taught the respiratory pharmacotherapy module in the pharmacy curriculum at HUCOP. Dr. Lajthia’s areas of interest include innovative technology in diabetes management, interprofessional education, and chronic disease management. 

Carla Williams, PhD, MPH

Associate Professor, Howard University College of Medicine

Bio:

Dr. Carla Williams received her Ph.D. in clinical psychology from Howard University. She is currently Associate Professor of Medicine and Public Health and Interim Director of the Howard University Cancer Center.   Her work centers around understanding and reducing cancer-related health disparities.  Her research activities emphasize engaging communities that have not been adequately represented in research.  Dr. Williams works with community health leaders to promote individual adoption of healthy lifestyle behaviors as well as population-level change in the environment, health policies, and health systems.  

Since 2010, Dr. Williams’ collaborative research efforts have resulted in the expansion of her role to function as an Executive Scientist.  In this capacity, she helps to build research teams within and across institutions to promote collaborative research.  She has led the development of a regional symposia to equip scientists and community health advocates with the skills to maximize the impact of collaborative research.   

In her teaching roles, Dr. Williams has developed new training paradigms to enhance students understanding and utilization of evidence-based practice.   She has also incorporated the use of reflective exercises to promote learning synthesis and integration.  Most recently, she has worked to develop a combined didactic and practice-based course that builds skills for community engagement as a key discipline in public health, health care research, and health policy.  

Bob Vollinger, Dr. P.H., M.S.P.H 

Program Director, Tobacco Control Research Branch Behavioral Research Program

Bio:

Dr. Vollinger serves as Program Director in the Tobacco Control Research Branch (TCRB) within the Behavioral Research Program (BRP) of the Division of Cancer Control and Population Sciences (DCCPS) at the National Cancer Institute (NCI). He manages a grants portfolio in State and Community Tobacco Control Policy and Media Research in TCRB. Dr. Vollinger previously managed the Tobacco Research Initiative for State and Community Interventions, which was the largest tobacco control research initiative at NCI and supported research on innovative tobacco prevention and control interventions at the community, State, and National level. The results have guided tobacco control programs across the Nation to increase program effectiveness and produce real reductions in the prevalence of tobacco use.

Additionally, he was co-Senior Scientific Editor of NCI Tobacco Control Monograph No. 16, ASSIST: Shaping the Future of Tobacco Prevention and Control. Previously Bob served as a Project Officer with the American Stop Smoking Intervention Study for Cancer Prevention (ASSIST) and managed numerous large contracts with State Health Departments, working closely with the American Cancer Society and other voluntary health organizations. He has provided technical assistance and training to State and local public health agencies, and major voluntary organizations regarding comprehensive tobacco prevention and control. He has worked on tobacco control research, policy, and media issues at NCI since 1996. 

Relevant Financial Relationships

The instructors, advisors, and planners of the course have no relevant financial relationships to declare.

Anti-discrimination Policy

The instructors, advisors, panelists, and course planners have agreed to our anti-discrimination policy that prohibits the inclusion of discriminatory language, graphics, or references on the basis of race, gender identity, age, color, national origin, physical or mental disability, or religion.